Follow
Vineela Parvathaneni, Ph.D.
Vineela Parvathaneni, Ph.D.
Scientist III at Thermo fisher scientific
Verified email at stjohns.edu
Title
Cited by
Cited by
Year
Drug repurposing: a promising tool to accelerate the drug discovery process
V Parvathaneni, NS Kulkarni, A Muth, V Gupta
Drug discovery today 24 (10), 2076-2085, 2019
3392019
Utilizing drug repurposing against COVID-19–efficacy, limitations, and challenges
V Parvathaneni, V Gupta
Life sciences 259, 118275, 2020
1182020
Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer
B Vaidya, V Parvathaneni, NS Kulkarni, SK Shukla, JK Damon, A Sarode, ...
International journal of biological macromolecules 122, 338-347, 2019
1032019
Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer
X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ...
International Journal of Biological Macromolecules 164, 638-650, 2020
692020
Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment
V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ...
Pharmaceutics 12 (3), 206, 2020
612020
Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer
SK Shukla, NS Kulkarni, A Chan, V Parvathaneni, P Farrales, A Muth, ...
Pharmaceutics 11 (11), 559, 2019
602019
Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ...
International journal of pharmaceutics 577, 118995, 2020
592020
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment
NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ...
European Journal of Pharmaceutical Sciences 133, 145-159, 2019
512019
Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer
SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ...
Pharmaceutical research 37, 1-19, 2020
492020
Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ...
Drug delivery and translational research 11, 927-943, 2021
452021
Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex
SK Shukla, A Chan, V Parvathaneni, DD Kanabar, K Patel, S Ayehunie, ...
Journal of Molecular Liquids 318, 113936, 2020
392020
Cyclodextrin complexation for enhanced stability and non-invasive pulmonary delivery of resveratrol—applications in non-small cell lung cancer treatment
X Wang, V Parvathaneni, SK Shukla, DD Kanabar, A Muth, V Gupta
Aaps Pharmscitech 21, 1-14, 2020
342020
Development of pharmaceutically scalable inhaled anti-cancer nanotherapy–repurposing amodiaquine for non-small cell lung cancer (NSCLC)
V Parvathaneni, NS Kulkarni, G Chauhan, SK Shukla, R Elbatanony, ...
Materials Science and Engineering: C 115, 111139, 2020
312020
Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma–a rare thoracic cancer
SK Shukla, A Chan, V Parvathaneni, V Gupta
International Journal of Biological Macromolecules 160, 128-141, 2020
312020
Repurposing bedaquiline for effective non-small cell lung cancer (NSCLC) therapy as inhalable cyclodextrin-based molecular inclusion complexes
V Parvathaneni, RS Elbatanony, M Goyal, T Chavan, N Vega, S Kolluru, ...
International journal of molecular sciences 22 (9), 4783, 2021
242021
Nanotechnology based repositioning of an anti-viral drug for non-small cell lung cancer (NSCLC)
V Parvathaneni, M Goyal, NS Kulkarni, SK Shukla, V Gupta
Pharmaceutical Research 37, 1-21, 2020
182020
Repurposing quinacrine for treatment of malignant mesothelioma: in-vitro therapeutic and mechanistic evaluation
NS Kulkarni, B Vaidya, V Parvathaneni, D Bhanja, V Gupta
International Journal of Molecular Sciences 21 (17), 6306, 2020
152020
Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation–Evaluation of intestinal absorption and anti-cancer activity
V Parvathaneni, RS Elbatanony, SK Shukla, NS Kulkarni, DD Kanabar, ...
Journal of Molecular Liquids 327, 114866, 2021
142021
Therapeutic potential of inhalable medications to combat coronavirus disease-2019
V Parvathaneni, NS Kulkarni, A Muth, NK Kunda, V Gupta
Therapeutic delivery 12 (2), 105-110, 2021
92021
Inhaled indomethacin-loaded liposomes as potential therapeutics against non-small cell lung cancer (NSCLC)
S Sarvepalli, V Parvathaneni, G Chauhan, SK Shukla, V Gupta
Pharmaceutical Research 39 (11), 2801-2815, 2022
82022
The system can't perform the operation now. Try again later.
Articles 1–20